NEAL COLLINS: Open Payments
NPI 1457370363 · GALLIPOLIS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 50 payments from 19 companies in 2025. Trend: 2023 $829 · 2024 $801 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 16 | $257 |
| Novo Nordisk Inc | 5 | $99 |
| CeQur Corporation | 1 | $66 |
| BETA BIONICS, INC. | 7 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Sequel Med Tech, LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| UCB, Inc. | 1 | $28 |
Products named: Dexcom G6 Transmitter, CeQur Simplicity, iLet Bionic Pancreas, JARDIANCE, INGREZZA, TZIELD, TWIIST, Kerendia.
Industry payments across OH — which companies pay providers there.
